Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Gynecology

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 17 articles: HTML format

Single Articles

May 2025
1. ZHU X, Fu Z, Aceto G, St-Germain J, et al
   SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancer.
   Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-24-3990.
   PubMed     Abstract available
   
   
   
2. ABBASI A, Steele CD, Bergstrom EN, Khandekar A, et al
   HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data.
   Cancer Res. 2025 May 6. doi: 10.1158/0008-5472.CAN-24-2639.
   PubMed     Abstract available
   
   
   April 2025
3. HOCKINGS H, Lakatos E, Huang W, Mossner M, et al
   Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.
   Cancer Res. 2025 Apr 29. doi: 10.1158/0008-5472.CAN-25-0351.
   PubMed     Abstract available
   
   
   
4. ZHANG C, Wang Y, He M, Wang C, et al
   Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites.
   Cancer Res. 2025 Apr 17. doi: 10.1158/0008-5472.CAN-24-3209.
   PubMed     Abstract available
   
   
   
5. DOMMER AP, Kumarasamy V, Wang J, O'Connor TN, et al
   Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222.
   Cancer Res. 2025;85:1310-1326.
   PubMed     Abstract available
   
   
   
6. STOJANOVIC L, Abbotts R, Tripathi K, Coon CM, et al
   ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.
   Cancer Res. 2025;85:1183-1198.
   PubMed     Abstract available
   
   
   March 2025
7. LAWSON-MICHOD KA, Marks JR, Collin LJ, Nix DA, et al
   Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals.
   Cancer Res. 2025 Mar 10. doi: 10.1158/0008-5472.CAN-24-1879.
   PubMed     Abstract available
   
   
   
8. WELTE T, Vuttaradhi VK, Khlebus EY, Brodsky A, et al
   Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors.
   Cancer Res. 2025;85:875-893.
   PubMed     Abstract available
   
   
   February 2025
9. HOUSE NC, Brown VE, Chen M, Yuan L, et al
   Profiling the Activity of the Potent and Highly Selective CDK2 Inhibitor BLU-222 Reveals Determinants of Response in CCNE1-Aberrant Ovarian and Endometrial Tumors.
   Cancer Res. 2025 Feb 13. doi: 10.1158/0008-5472.CAN-24-2360.
   PubMed     Abstract available
   
   
   January 2025
10. DEY P, Brisken C
    Breaking the Rhythm: Harnessing the Menstrual Cycle for Better Chemotherapy.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-25-0335.
    PubMed     Abstract available
    
    
    November 2024
11. MANDAL J, Jones TN, Liberto JM, Gaillard S, et al
    Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA Replication.
    Cancer Res. 2024;84:3881-3893.
    PubMed     Abstract available
    
    
    
12. HAANEN TJ, Boock S, Callahan CG, Peris I, et al
    Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer.
    Cancer Res. 2024 Nov 12. doi: 10.1158/0008-5472.CAN-24-1263.
    PubMed     Abstract available
    
    
    October 2024
13. DA COSTA AA, Somuncu O, Ravindranathan R, Mukkavalli S, et al
    Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor Sensitivity.
    Cancer Res. 2024;84:3435-3446.
    PubMed     Abstract available
    
    
    August 2024
14. SPEAR S, Le Saux O, Mirza HB, Iyer N, et al
    PTEN loss shapes macrophage dynamics in high grade serous ovarian carcinoma.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-3890.
    PubMed     Abstract available
    
    
    May 2024
15. JOY JD, Malacrida B, Laforets F, Kotantaki P, et al
    Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR T cell activity.
    Cancer Res. 2024 May 31. doi: 10.1158/0008-5472.CAN-23-3007.
    PubMed     Abstract available
    
    
    April 2024
16. WATERS JA, Robinson M, Lujano-Olazaba O, Lucht C, et al
    Omental preadipocytes stimulate matrix remodeling and IGF signaling to support ovarian cancer metastasis.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2613.
    PubMed     Abstract available
    
    
    March 2024
17. RAMANARAYANAN V, Oberdoerffer P
    AKTing on R Loops Makes for an ATRactive Target in Ovarian Cancer Therapy.
    Cancer Res. 2024;84:793-795.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.